AdJane is a clinical-stage vaccine platform company focused on pandemic preparedness and global health. Our approach is platform-driven: we develop and apply a scalable vaccine technology that can be selectively partnered with to accelerate global health impact.

Our next-generation platform has been scientifically developed over 30 years by Dutch governmental institutions. AdJane has consolidated this extensive scientific development history and advanced the platform to operational readiness for antigen display and adjuvant applications.

We operate with a long-term perspective, combining clinical experience, manufacturing readiness and strategic governance to support sustainable preparedness.

AdJane operates within the broader FDI ecosystem.